| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.34 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |